Omni Peptides

CJC-1295 NO DAC (Mod GRF 1-29)

Dhs. 400.00 AED

Sale Sold out

VIAL

Freeze-dried powder in a sealed glass vial. Reconstitute with bacteriostatic water and administer via syringe. The most versatile and cost-effective research format.

RECONSTITUTION & SYRINGE REQUIRED

CARTRIDGE

Pre-filled and ready to administer. Slides into a reusable pen injector — no measuring or mixing required. Clean, discreet, and consistent across research protocols.

REQUIRES COMPATIBLE PEN INJECTOR

NASAL

Delivered via mucosal absorption — no needles required. A popular choice for research protocols where needle-free administration is preferred.

NEEDLE-FREE — SPRAY & GO

PEN

An all-in-one auto-injector with the cartridge pre-loaded. Dial, click, and administer. Optimal for high-frequency research protocols requiring precise, repeatable dosing.

DIAL, CLICK & INJECT — NO PREP

Vials are freeze-dried (lyophilised) powder — kept refrigerated unopened, they remain stable for up to 2 years.

Cartridges, nasal sprays, and pens arrive pre-filled as liquid, must be kept refrigerated at all times, and carry a Beyond Use Date — typically 4–8 weeks from receipt. Please refer to the BUD on the label.

Size 5mg 10mg

CJC-1295 No DAC (also known as Mod GRF (1-29) or tetrasubstituted GRF (1-29)) is a synthetic 29-amino-acid polypeptide analog of growth hormone-releasing hormone (GHRH), featuring four strategic amino acid substitutions (at positions 2, 8, 15, and 27) designed to dramatically enhance stability and resistance to enzymatic degradation compared to native GHRH. Unlike the DAC-containing version, CJC-1295 No DAC has a short half-life (approximately 6–8 minutes), resulting in more physiological, pulsatile stimulation of endogenous growth hormone (GH) secretion. This research compound has attracted significant scientific interest for its potent and selective activation of pituitary somatotropes. Preliminary and advanced preclinical studies indicate that CJC-1295 No DAC may robustly increase GH and IGF-1 levels in a natural pulsatile pattern, support anabolic processes, enhance recovery, and promote favorable changes in body composition. Researchers utilize this peptide in laboratory and animal models to investigate mechanisms of GH axis physiology, pulsatile hormone release, tissue repair, and age-related endocrine modulation. As a research-grade compound, CJC-1295 No DAC is intended exclusively for in vitro and animal studies. Scientists value its clean pharmacokinetic profile, minimal off-target hormonal effects, and utility in studying natural GH pulsatility versus sustained release patterns.

Molecular Formula

C₁₅₂H₂₅₂N₄₄O₄₂

Molecular Weight

3367.9 g/mol

Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ (C-terminal amidation; key substitutions: D-Ala², Gln⁸, Ala¹⁵, Leu²⁷)

Research Applications

Pulsatile Growth Hormone Secretion
Preclinical investigations demonstrate that CJC-1295 No DAC elicits strong, dose-dependent, and naturally pulsatile GH release by activating GHRH receptors on pituitary somatotrophs. Studies emphasize its ability to mimic physiological GH secretion patterns more closely than long-acting analogs, preserving feedback regulation.
Body Composition and Anabolic Research
Research shows increases in lean body mass, improvements in nitrogen retention, and enhanced protein synthesis in various animal models. It has been explored for potential applications in sarcopenia, cachexia, muscle wasting, and post-injury recovery.
Synergistic Secretagogue Combinations
CJC-1295 No DAC is frequently studied in combination with GHS compounds (e.g., Ipamorelin, GHRP-6) to achieve synergistic amplification of GH pulses, resulting in greater overall GH/IGF-1 output while maintaining selectivity and minimizing side effects.
Fat Metabolism and Lipolysis
Investigations indicate enhanced lipolytic activity and reductions in fat mass in preclinical obesity and metabolic models, often attributed to elevated GH levels and improved insulin sensitivity in certain contexts.
Tissue Repair and Recovery
Studies suggest benefits in accelerating wound healing, tendon/ligament repair, cartilage regeneration, and bone metabolism through GH/IGF-1-mediated pathways. Research explores its role in models of aging, traumatic injury, and surgical recovery.

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.